Publications 2024
Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries
Clin Epigenetics, 16 (1), 56
DOI 10.1186/s13148-024-01669-z, PubMed 38643219
A DWI-based hypoxia model shows robustness in an external prostatectomy cohort
Front Oncol, 14, 1433197
DOI 10.3389/fonc.2024.1433197, PubMed 39109282
ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription
Theranostics, 14 (2), 714-737
DOI 10.7150/thno.88057, PubMed 38169509
An Immune Gene Expression Risk Score for Distant Metastases after Radiotherapy for Cervical Cancer
Clin Cancer Res, 30 (6), 1200-1207
DOI 10.1158/1078-0432.CCR-23-2085, PubMed 38180733
A T2-weighted MRI-based radiomic signature for disease-free survival in locally advanced cervical cancer following chemoradiation: An international, multicentre study
Radiother Oncol, 199, 110463
DOI 10.1016/j.radonc.2024.110463, PubMed 39067707
Spatial analysis of microRNA regulation at defined tumor hypoxia levels reveals biological traits of aggressive prostate cancer
J Pathol (in press)
DOI 10.1002/path.6344, PubMed 39329425
MRI-guided dynamic risk assessment in cervical cancer based on tumor hypoxia at diagnosis and volume response at brachytherapy
Radiother Oncol, 195, 110263
DOI 10.1016/j.radonc.2024.110263, PubMed 38556173
Publications 2023
Exploring Hypoxia in Prostate Cancer With T2-weighted Magnetic Resonance Imaging Radiomics and Pimonidazole Scoring
Anticancer Res, 43 (1), 351-357
DOI 10.21873/anticanres.16170, PubMed 36585179
Prostate cancer radiogenomics reveals proliferative gene expression programs associated with distinct MRI-based hypoxia levels
Radiother Oncol, 188, 109875
DOI 10.1016/j.radonc.2023.109875, PubMed 37640161
Publications 2022
Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance
Nat Commun, 13 (1), 5818
DOI 10.1038/s41467-022-33544-x, PubMed 36207323
Targeted Therapy on the Screen: Do We Hit the Target?
Clin Cancer Res, 28 (24), 5233-5234
DOI 10.1158/1078-0432.CCR-22-2707, PubMed 36240006
miR-200a/b/-429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer
Mol Oncol, 16 (6), 1402-1419
DOI 10.1002/1878-0261.13184, PubMed 35064630
A prognostic hypoxia gene signature with low heterogeneity within the dominant tumour lesion in prostate cancer patients
Br J Cancer, 127 (2), 321-328
DOI 10.1038/s41416-022-01782-x, PubMed 35332267
Risk of recurrence after chemoradiotherapy identified by multimodal MRI and 18F-FDG-PET/CT in locally advanced cervical cancer
Radiother Oncol, 176, 17-24
DOI 10.1016/j.radonc.2022.09.002, PubMed 36113778
Publications 2021
Tumor Hypoxia as a Barrier in Cancer Therapy: Why Levels Matter
Cancers (Basel), 13 (3)
DOI 10.3390/cancers13030499, PubMed 33525508
Amino acid transporter expression and 18F-FACBC uptake at PET in primary prostate cancer
Am J Nucl Med Mol Imaging, 11 (4), 250-259
PubMed 34513278
Publications 2020
Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity
EBioMedicine, 57, 102841
DOI 10.1016/j.ebiom.2020.102841, PubMed 32580139
MRI Distinguishes Tumor Hypoxia Levels of Different Prognostic and Biological Significance in Cervical Cancer
Cancer Res, 80 (18), 3993-4003
DOI 10.1158/0008-5472.CAN-20-0950, PubMed 32606004
Publications 2019
Mitochondrial Function of CKS2 Oncoprotein Links Oxidative Phosphorylation with Cell Division in Chemoradioresistant Cervical Cancer
Neoplasia, 21 (4), 353-362
DOI 10.1016/j.neo.2019.01.002, PubMed 30856376
Reference MicroRNAs for RT-qPCR Assays in Cervical Cancer Patients and Their Application to Studies of HPV16 and Hypoxia Biomarkers
Transl Oncol, 12 (3), 576-584
DOI 10.1016/j.tranon.2018.12.010, PubMed 30660934
Influx rate of 18F-fluoroaminosuberic acid reflects cystine/glutamate antiporter expression in tumour xenografts
Eur J Nucl Med Mol Imaging, 46 (10), 2190-2198
DOI 10.1007/s00259-019-04375-8, PubMed 31264167
PTEN Expression in Prostate Cancer: Relationship With Clinicopathologic Features and Multiparametric MRI Findings
AJR Am J Roentgenol, 212 (6), 1206-1214
DOI 10.2214/AJR.18.20743, PubMed 30888866
Publications 2018
Combined MR Imaging of Oxygen Consumption and Supply Reveals Tumor Hypoxia and Aggressiveness in Prostate Cancer Patients
Cancer Res, 78 (16), 4774-4785
DOI 10.1158/0008-5472.CAN-17-3806, PubMed 29945958
Transkingdom network reveals bacterial players associated with cervical cancer gene expression program
PeerJ, 6, e5590
DOI 10.7717/peerj.5590, PubMed 30294508
Potentials and challenges of diffusion-weighted magnetic resonance imaging in radiotherapy
Clin Transl Radiat Oncol, 13, 29-37
DOI 10.1016/j.ctro.2018.09.002, PubMed 30294681
Low dose-rate irradiation with [3H]-labelled valine to selectively target hypoxic cells in a human colorectal cancer xenograft model
Acta Oncol, 57 (9), 1216-1224
DOI 10.1080/0284186X.2018.1457223, PubMed 29630428
Publications 2017
Dynamic contrast enhanced magnetic resonance imaging for hypoxia mapping and potential for brachytherapy targeting
Phys. Imag. Radiat. Oncol., 2, 1-6
DOI 10.1016/j.phro.2017.03.002
Hypoxia in cervical cancer: from biology to imaging
Clin Transl Imaging, 5 (4), 373-388
DOI 10.1007/s40336-017-0238-7, PubMed 28804704
Autodelineation of cervical cancers using multiparametric magnetic resonance imaging and machine learning
Acta Oncol, 56 (6), 806-812
DOI 10.1080/0284186X.2017.1285499, PubMed 28464746
Publications 2016
Integrative Analysis of DCE-MRI and Gene Expression Profiles in Construction of a Gene Classifier for Assessment of Hypoxia-Related Risk of Chemoradiotherapy Failure in Cervical Cancer
Clin Cancer Res, 22 (16), 4067-76
DOI 10.1158/1078-0432.CCR-15-2322, PubMed 27012812
Identification and Validation of Reference Genes for RT-qPCR Studies of Hypoxia in Squamous Cervical Cancer Patients
PLoS One, 11 (5), e0156259
DOI 10.1371/journal.pone.0156259, PubMed 27244197
Hypoxia-induced alterations of G2 checkpoint regulators
Mol Oncol, 10 (5), 764-73
DOI 10.1016/j.molonc.2015.12.015, PubMed 26791779
Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition
Br J Cancer, 115 (8), 929-939
DOI 10.1038/bjc.2016.278, PubMed 27599042
Cluster analysis of dynamic contrast enhanced MRI reveals tumor subregions related to locoregional relapse for cervical cancer patients
Acta Oncol, 55 (11), 1294-1298
DOI 10.1080/0284186X.2016.1189091, PubMed 27564398
Aberrant methylation-mediated silencing of microRNAs contributes to HPV-induced anchorage independence
Oncotarget, 7 (28), 43805-43819
DOI 10.18632/oncotarget.9698, PubMed 27270309
Publications 2015
Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer
Epigenetics, 10 (10), 970-80
DOI 10.1080/15592294.2015.1085140, PubMed 26291246
Publications 2014
Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium
J Enzyme Inhib Med Chem, 30 (5), 689-721
DOI 10.3109/14756366.2014.966704, PubMed 25347767
The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer
Br J Cancer, 112 (2), 382-90
DOI 10.1038/bjc.2014.604, PubMed 25461803
Ménage à trois: an evolutionary interplay between human papillomavirus, a tumor, and a woman
Trends Microbiol, 22 (6), 345-53
DOI 10.1016/j.tim.2014.02.009, PubMed 24674660
Classification of dynamic contrast enhanced MR images of cervical cancers using texture analysis and support vector machines
IEEE Trans Med Imaging, 33 (8), 1648-56
DOI 10.1109/TMI.2014.2321024, PubMed 24802069
Publications 2013
Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome
Radiother Oncol, 107 (1), 117-22
DOI 10.1016/j.radonc.2012.11.007, PubMed 23333024
Identification of eight candidate target genes of the recurrent 3p12-p14 loss in cervical cancer by integrative genomic profiling
J Pathol, 230 (1), 59-69
DOI 10.1002/path.4168, PubMed 23335387
Gene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancer
Nat Commun, 4, 1806
DOI 10.1038/ncomms2693, PubMed 23651994
Hypoxia-independent downregulation of hypoxia-inducible factor 1 targets by androgen deprivation therapy in prostate cancer
Int J Radiat Oncol Biol Phys, 87 (4), 753-60
DOI 10.1016/j.ijrobp.2013.07.023, PubMed 24035332
Publications 2012
Hypoxia-induced gene expression in chemoradioresistant cervical cancer revealed by dynamic contrast-enhanced MRI
Cancer Res, 72 (20), 5285-95
DOI 10.1158/0008-5472.CAN-12-1085, PubMed 22890239
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
Radiat Oncol, 7, 75
DOI 10.1186/1748-717X-7-75, PubMed 22621752
Publications 2011
Dynamic contrast-enhanced MRI of cervical cancers: temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistance
Int J Radiat Oncol Biol Phys, 82 (3), e485-92
DOI 10.1016/j.ijrobp.2011.05.050, PubMed 22014954
Pharmacokinetic analysis and k-means clustering of DCEMR images for radiotherapy outcome prediction of advanced cervical cancers
Acta Oncol, 50 (6), 859-65
DOI 10.3109/0284186X.2011.578586, PubMed 21767185
Weighted lasso with data integration
Stat Appl Genet Mol Biol, 10 (1)
DOI 10.2202/1544-6115.1703, PubMed 23089821
Phosphorylation of EGFR measured with in situ proximity ligation assay: relationship to EGFR protein level and gene dosage in cervical cancer
Radiother Oncol, 101 (1), 152-7
DOI 10.1016/j.radonc.2011.05.052, PubMed 21680035
Membranous expression of ectodomain isoforms of the epidermal growth factor receptor predicts outcome after chemoradiotherapy of lymph node-negative cervical cancer
Clin Cancer Res, 17 (16), 5501-12
DOI 10.1158/1078-0432.CCR-11-0297, PubMed 21737508
Three independent mechanisms for arrest in G2 after ionizing radiation
Cell Cycle, 10 (5), 819-29
DOI 10.4161/cc.10.5.14968, PubMed 21325885
Publications 2009
Expression of 14-3-3sigma in cervical squamous cell carcinomas: relationship with clinical outcome
Oncol Rep, 22 (1), 11-5
DOI 10.3892/or_00000399, PubMed 19513498
Gene dosage, expression, and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancer
PLoS Genet, 5 (11), e1000719
DOI 10.1371/journal.pgen.1000719, PubMed 19911042
Publications 2008
Indirect genomic effects on survival from gene expression data
Genome Biol, 9 (3), R58
DOI 10.1186/gb-2008-9-3-r58, PubMed 18358079
Human papillomavirus DNA and e6/e7 mRNA status in relation to survival of patients treated for cervical squamous cell carcinoma
Open Virol J, 2, 74-81
DOI 10.2174/1874357900802010074, PubMed 19440467
GeneCount: genome-wide calculation of absolute tumor DNA copy numbers from array comparative genomic hybridization data
Genome Biol, 9 (5), R86
DOI 10.1186/gb-2008-9-5-r86, PubMed 18500990
Validation of oligoarrays for quantitative exploration of the transcriptome
BMC Genomics, 9, 258
DOI 10.1186/1471-2164-9-258, PubMed 18513391
Publications 2007
Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas
BMC Cancer, 7, 11
DOI 10.1186/1471-2407-7-11, PubMed 17233882
Publications 2006
Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer
BMC Genomics, 7, 268
DOI 10.1186/1471-2164-7-268, PubMed 17054779
Publications 2005
Genome-wide estimation of transcript concentrations from spotted cDNA microarray data
Nucleic Acids Res, 33 (17), e143
DOI 10.1093/nar/gni141, PubMed 16204447
Response of malignant B lymphocytes to ionizing radiation: gene expression and genotype
Int J Cancer, 115 (6), 935-42
DOI 10.1002/ijc.20962, PubMed 15723354
The influence of missing value imputation on detection of differentially expressed genes from microarray data
Bioinformatics, 21 (23), 4272-9
DOI 10.1093/bioinformatics/bti708, PubMed 16216830
Publications 2004
The response of malignant B lymphocytes to ionizing radiation: cell cycle arrest, apoptosis and protection against the cytotoxic effects of the mitotic inhibitor nocodazole
Radiat Res, 162 (4), 405-15
DOI 10.1667/rr3235, PubMed 15447042
Profound influence of microarray scanner characteristics on gene expression ratios: analysis and procedure for correction
BMC Genomics, 5 (1), 10
DOI 10.1186/1471-2164-5-10, PubMed 15018648
Intratumor chromosomal heterogeneity in advanced carcinomas of the uterine cervix
Int J Cancer, 111 (3), 358-66
DOI 10.1002/ijc.20258, PubMed 15221962
Publications 2001
Serial changes in tumor oxygenation during the early phase of radiation therapy in cervical cancer - Are we quantitating hypoxia change? Response
Int. J. Radiat. Oncol. Biol. Phys., 49 (1), 285-289
DOI 10.1016/S0360-3016(00)00795-1
Intra- and intertumor heterogeneity in blood perfusion of human cervical cancer before treatment and after radiotherapy
Int J Cancer, 96 (3), 182-90
DOI 10.1002/ijc.1019, PubMed 11410887
Assessment of tumor oxygenation in human cervical carcinoma by use of dynamic Gd-DTPA-enhanced MR imaging
J Magn Reson Imaging, 14 (6), 750-6
DOI 10.1002/jmri.10016, PubMed 11747032
Microvessel oxyhemoglobin saturation does not reflect tissue oxygen tension in human melanoma xenografts
Microvasc Res, 61 (2), 199-202
DOI 10.1006/mvre.2000.2294, PubMed 11254399
Publications 2000
Intratumor heterogeneity in perfusion in human melanoma xenografts measured by contrast-enhanced magnetic resonance imaging
Magn Reson Imaging, 18 (8), 997-1002
DOI 10.1016/s0730-725x(00)00188-0, PubMed 11121704
Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging
Magn Reson Med, 43 (6), 828-36
DOI 10.1002/1522-2594(200006)43:6<828::aid-mrm8>3.0.co;2-p, PubMed 10861877
Changes in tumor oxygen tension during radiotherapy of uterine cervical cancer: relationships to changes in vascular density, cell density, and frequency of mitosis and apoptosis
Int J Radiat Oncol Biol Phys, 46 (4), 935-46
DOI 10.1016/s0360-3016(99)00497-6, PubMed 10705016
Disease control of uterine cervical cancer: relationships to tumor oxygen tension, vascular density, cell density, and frequency of mitosis and apoptosis measured before treatment and during radiotherapy
Clin Cancer Res, 6 (3), 1104-12
PubMed 10741740
Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis
Br J Cancer, 83 (3), 354-9
DOI 10.1054/bjoc.2000.1266, PubMed 10917551
Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumor oxygenation and vascularization
Radiother Oncol, 54 (2), 101-7
DOI 10.1016/s0167-8140(99)00175-9, PubMed 10699471
Publications 1999
Changes in oxygen tension during radiotherapy of head and neck tumours
Acta Oncol, 38 (8), 1037-42
DOI 10.1080/028418699432329, PubMed 10665759
Measurement of proliferation activity in human melanoma xenografts by magnetic resonance imaging
Magn Reson Imaging, 17 (3), 393-402
DOI 10.1016/s0730-725x(98)00175-1, PubMed 10195582
Publications 1998
Measurement of perfusion rate in human melanoma xenografts by contrast-enhanced magnetic resonance imaging
Magn Reson Med, 40 (1), 89-98
DOI 10.1002/mrm.1910400113, PubMed 9660558
Oxygen tension and not vascular density or apoptosis predicts for metastasis in human cervix carcinoma
20TH EUROPEAN CONFERENCE ON MICROCIRCULATION, 13-17
Oxygen tension in human squamous cell carcinoma and adenocarcinoma of the uterine cervix
Adv Exp Med Biol, 454, 635-41
DOI 10.1007/978-1-4615-4863-8_75, PubMed 9889944
Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix
Br J Cancer, 78 (6), 822-7
DOI 10.1038/bjc.1998.586, PubMed 9743308
Oxygen tension and vascular density in adenocarcinoma and squamous cell carcinoma of the uterine cervix
Acta Oncol, 37 (7-8), 665-70
DOI 10.1080/028418698430016, PubMed 10050984
Vascular density in human melanoma xenografts: relationship to angiogenesis, perfusion and necrosis
Cancer Lett, 123 (2), 159-65
DOI 10.1016/s0304-3835(97)00424-2, PubMed 9489483
Publications 1997
Oxygen tension in human tumours measured with polarographic needle electrodes and its relationship to vascular density, necrosis and hypoxia
Radiother Oncol, 44 (2), 163-9
DOI 10.1016/s0167-8140(97)01920-8, PubMed 9288845
Oxygen tension in primary tumours of the uterine cervix and lymph node metastases of the head and neck
Adv Exp Med Biol, 428, 55-60
DOI 10.1007/978-1-4615-5399-1_9, PubMed 9500029
Proton relaxation times and interstitial fluid pressure in human melanoma xenografts
Br J Cancer, 75 (2), 180-3
DOI 10.1038/bjc.1997.30, PubMed 9010023
Angiogenesis in tumor growth and metastasis
In Pathology Update (Nesland JM, ed.), Gustav Fischer, Jena, 4, 97-108
PublikaID 42, ISBN 3-437-31088-7
Polarographic measurement of pO2 in cervix carcinoma
Gynecol Oncol, 64 (2), 230-6
DOI 10.1006/gyno.1996.4571, PubMed 9038268
Correlation of high lactate levels in head and neck tumors with incidence of metastasis
Am J Pathol, 150 (2), 409-15
PubMed 9033256
Publications 1996
Oxygen tension and vascular density in human cervix carcinoma
Br J Cancer, 74 (10), 1559-63
DOI 10.1038/bjc.1996.589, PubMed 8932335
Apoptosis, energy metabolism, and fraction of radiobiologically hypoxic cells: a study of human melanoma multicellular spheroids
Int J Radiat Biol, 70 (3), 241-9
DOI 10.1080/095530096144978, PubMed 8800195
Hypoxia-induced tetraploidisation of a diploid human melanoma cell line in vitro
Br J Cancer Suppl, 27, S136-9
PubMed 8763866
Xenograft model systems for human melanoma
Mol Med Today, 2 (9), 394-403
DOI 10.1016/s1357-4310(96)10035-6, PubMed 8885259
Interstitial fluid pressure, perfusion rate and oxygen tension in human melanoma xenografts
Br J Cancer Suppl, 27, S252-5
PubMed 8763891
Publications 1995
Detection of necrosis in human tumour xenografts by proton magnetic resonance imaging
Br J Cancer, 71 (3), 456-61
DOI 10.1038/bjc.1995.93, PubMed 7880724
MRI of human tumor xenografts in vivo: proton relaxation times and extracellular tumor volume
Magn Reson Imaging, 13 (5), 693-700
DOI 10.1016/0730-725x(95)00019-d, PubMed 8569443
31P NMR spectroscopy studies of phospholipid metabolism in human melanoma xenograft lines differing in rate of tumour cell proliferation
NMR Biomed, 8 (2), 65-71
DOI 10.1002/nbm.1940080204, PubMed 7547188
Treatment failure following sequential thermoradiotherapy of locally advanced breast carcinoma occurs primarily in poorly vascularized tumors
Oncology, 52 (6), 443-7
DOI 10.1159/000227508, PubMed 7478428
Heterogeneity in pO2 and histological appearance in human cervix carcinoma.
In Tumor Oxygenation (Vaupel P, Kelleher DK, Günderoth M, eds.), Gustav Fischer Verlag, New York, 249-258
PublikaID 43
Spin-lattice relaxation time of inorganic phosphate in human tumor xenografts measured in vivo by 31P-magnetic resonance spectroscopy. Influence of oxygen tension
Acta Oncol, 34 (3), 339-43
DOI 10.3109/02841869509093986, PubMed 7779420
Effect of melanin on phosphorus T1S in human melanoma xenografts studied by 31P MRS
Magn Reson Imaging, 13 (6), 847-52
DOI 10.1016/0730-725x(95)00054-k, PubMed 8544656
Publications 1994
31P-nuclear magnetic resonance spectroscopy in vivo of four human melanoma xenograft lines: spin-lattice relaxation times
Radiother Oncol, 32 (1), 54-62
DOI 10.1016/0167-8140(94)90449-9, PubMed 7938679
Non-invasive assessment of tumor oxygenation status by integrated 31P NMR spectroscopy and 1H NMR imaging
Adv Exp Med Biol, 345, 531-8
DOI 10.1007/978-1-4615-2468-7_71, PubMed 8079755
Magnetic resonance imaging of human melanoma xenografts in vivo: proton spin-lattice and spin-spin relaxation times versus fractional tumour water content and fraction of necrotic tumour tissue
Int J Radiat Biol, 65 (3), 387-401
DOI 10.1080/09553009414550451, PubMed 7908318
Publications 1993
Blood flow and thermoradiotherapy of locally advanced breast carcinoma
Department of Biophysics, the Norwegian Radium Hospital and The Norwegian Cancer Society, [Oslo], 1 b. (flere pag.)
BIBSYS 931214912, ISBN 82-992250-1-9
Prediction of treatment temperatures in clinical hyperthermia of locally advanced breast carcinoma: the use of contrast enhanced computed tomography
Int J Radiat Oncol Biol Phys, 26 (3), 451-7
DOI 10.1016/0360-3016(93)90963-v, PubMed 8390419
31P-nuclear magnetic resonance spectroscopy in vivo of six human melanoma xenograft lines: tumour bioenergetic status and blood supply
Br J Cancer, 68 (6), 1061-70
DOI 10.1038/bjc.1993.483, PubMed 8260356
Thermal dose and secondary tumour cell death
Int J Hyperthermia, 9 (5), 755-61
DOI 10.3109/02656739309032062, PubMed 8245585
Publications 1992
Blood flow in six human melanoma xenograft lines with different growth characteristics
Cancer Res, 52 (3), 584-92
PubMed 1732046
Publications 1991
Temperature distribution in locally advanced breast carcinoma during hyperthermic treatment: relationship to perfusion, vascular density, and histology
Int J Radiat Oncol Biol Phys, 21 (2), 423-30
DOI 10.1016/0360-3016(91)90791-2, PubMed 1648045
Changes in temperatures and thermal doses with fraction number during hyperthermic treatment of locally advanced breast carcinoma
Int J Hyperthermia, 7 (6), 815-25
DOI 10.3109/02656739109056450, PubMed 1666900
The relevance of tumour and surrounding normal tissue vascular density in clinical hyperthermia of locally advanced breast carcinoma
Int J Radiat Biol, 60 (1-2), 189-93
DOI 10.1080/09553009114551821, PubMed 1677970
Relationships between thermal dose and heat-induced tissue and vascular damage after thermoradiotherapy of locally advanced breast carcinoma
Int J Hyperthermia, 7 (3), 403-15
DOI 10.3109/02656739109005006, PubMed 1919137
Publications 1990
Positioning of temperature measurement points using multiplanar computed tomography
Int J Hyperthermia, 6 (5), 957-60
DOI 10.3109/02656739009140977, PubMed 2250121